INHIBITION OF PROTEIN DENATURATION BY ANTIRHEUMATIC OR ANTIPHLOGISTIC AGENTS.
D000632:Aminopyrine; D010131:Aminosalicylic Acid; D000636:Aminosalicylic Acids; D000983:Antipyrine; D018501:Antirheumatic Agents; D001241:Aspirin; D005841:Gentisates; D006358:Hot Temperature; D010113:Oxyphenbutazone; D010600:Pharmacology; D010653:Phenylbutazone; D011489:Protein Denaturation; D011803:Quinine; D012106:Research; D012457:Salicylamides; D012709:Serum Albumin; D012980:Sodium Salicylate; D013501:Surface-Active Agents; D014466:Ultraviolet Rays; D014508:Urea; D005719:gamma-Globulins
D000636:Aminosalicylic Acids; D018501:Antirheumatic Agents; D005841:Gentisates; D012457:Salicylamides; D012709:Serum Albumin; D013501:Surface-Active Agents; D005719:gamma-Globulins; D000632:Aminopyrine; D010131:Aminosalicylic Acid; D014508:Urea; D011803:Quinine; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D001241:Aspirin; D000983:Antipyrine; D012980:Sodium Salicylate
AMINOPYRINE; AMINOSALICYLIC ACID; ANTIPYRINE; ASPIRIN; EXPERIMENTAL LAB STUDY; GAMMA GLOBULIN; GENTISATES; HEAT; OXYPHENBUTAZONE; PHARMACOLOGY; PHENYLBUTAZONE; QUININE; SALICYLAMIDES; SERUM ALBUMIN; SODIUM SALICYLATE; SURFACE-ACTIVE AGENTS; ULTRAVIOLET RAYS; UREA